EUVIMEDEUVIMED entdecken
Crossref

LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy

Veronika A. Myasoedova, Nikolay A. Orekhov, Alexey V. Churov, Alexander N. Orekhov

Gene Expression · 30.07.2026 · 25 (3)

DOI: 10.14218/ge.2024.00062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene Expression, online erschienen am 29.07.2026. Verfasst von Veronika A. Myasoedova und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Myasoedova, V. A., Orekhov, N. A., Churov, A. V., & Orekhov, A. N. (2026). LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy. Gene Expression, 25(3). https://doi.org/10.14218/ge.2024.00062

Vancouver

Myasoedova VA, Orekhov NA, Churov AV, Orekhov AN. LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy. Gene Expression. 2026;25(3). doi:10.14218/ge.2024.00062

BibTeX
@article{Myasoedova2026,
  author = {Myasoedova, Veronika A. and Orekhov, Nikolay A. and Churov, Alexey V. and Orekhov, Alexander N.},
  title = {LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy},
  journal = {Gene Expression},
  year = {2026},
  volume = {25},
  number = {3},
  doi = {10.14218/ge.2024.00062}
}
Kostenlos starten →